- Home
- SYNX vs SBFM Comparison
SYNX vs SBFM Comparison
Compare SYNX & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYNX | SBFM |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 7.2M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYNX | SBFM |
|---|---|---|
| Price | $0.77 | $1.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 208.5K | 55.0K |
| Earning Date | 09-26-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,003,000.00 | ★ $37,323,742.00 |
| Revenue This Year | $32.35 | $10.26 |
| Revenue Next Year | N/A | $32.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.24 |
| 52 Week Low | $0.76 | $1.17 |
| 52 Week High | $6.49 | $3.90 |
Technical Indicators
Market Signals| Indicator | SYNX | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 32.52 | 37.32 |
| Support Level | $0.76 | $1.32 |
| Resistance Level | $0.86 | $1.48 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 6.35 | 16.67 |
Price Performance
Historical ComparisonAbout SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.